Artemisia lactiflora
Artemisia lactiflora · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Artemisia lactiflora is a medicinal plant that has garnered significant scientific interest due to its diverse pharmacological activities. Research indicates that extracts and specific fractions, such as the butanol and ethyl acetate fractions, possess potent antioxidant and antitumor properties. The therapeutic potential of its leaves is driven by key chemical constituents, including dihydroactinidiolide, dehydrovomifoliol, megastigmatrienone, and alpha-curcumene. These bioactive compounds are being closely studied for their ability to combat various pathological conditions, most notably lung cancer. Consequently, the various preparations of this plant represent a promising area of study for targeted cancer therapies.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Artemisia lactiflora is a versatile botanical species known by a diverse array of regional and linguistic names. In certain areas, it is commonly referred to as Guizhou mugwort, highlighting its specific geographic associations. The plant also carries the Dutch name Witte bijvoet, reflecting its presence in European nomenclature. French speakers may identify it as armoise à fleurs blanches or armoise à fleurs laiteuses, both of which describe its distinct white floral characteristics. Furthermore, it is recognized by the name kiinanmaruna, illustrating the wide range of cultural identities this single species holds.
Sources: Catalogue of Life (COL)
Taxonomy
Artemisia lactiflora is a distinctive botanical specimen that belongs to the vast kingdom Plantae. Within this biological realm, it is categorized under the class Equisetopsida. It further belongs to the order Asterales, a group known for its diverse floral characteristics. This plant is a member of the prominent family Asteraceae, which contains many familiar flowering species. Ultimately, it is classified under the specific genus Artemisia, highlighting its unique evolutionary lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Artemisia lactiflora is a resilient species with a broad geographical footprint across various Asian climates. It is widely distributed throughout the temperate regions of China, spanning from the North-Central areas to the South-Central and Southeast provinces. Beyond mainland China, the plant can also be found thriving in the temperate landscapes of Taiwan. Its adaptability is further evidenced by its presence in the tropical environments of the Indian Subcontinent, specifically within Assam. This diverse range highlights the plant's ability to inhabit a wide variety of ecological niches across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Artemisia lactiflora is characterized by its distinct herbaceous growth form. This plant structure allows it to remain entirely self-supporting throughout its development.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Artemisia lactiflora serves as a significant medicinal plant that hosts a diverse range of endophytic fungi. Research indicates that these fungi can be a rich source of bioactive components with specific therapeutic properties. Specifically, studies have identified various isolates from the plant that possess notable antitumor activity against several cancer cell lines. Furthermore, certain strains extracted from the plant also demonstrate effective antioxidant capabilities. These findings highlight the potential of Artemisia lactiflora as a valuable resource for discovering new medicinal agents.
Compounds
Artemisia lactiflora is a traditional Chinese medicinal plant recognized for its antioxidant and anti-inflammatory properties. Recent phytochemical analysis of its diethyl ether extract has identified several significant terpenoids. Specifically, the plant contains dihydroactinidiolide, dehydrovomifoliol, megastigmatrienone, and alpha-curcumene. These compounds were identified as the most intense peaks during LC-MS/MS testing. Notably, the presence of dihydroactinidiolide shows great promise due to its ability to inhibit the migration and invasion of non-small cell lung cancer cells.
Conditions
Artemisia lactiflora serves as a traditional medicinal plant used to treat menstrual and hepatic disorders due to its antioxidant and anti-inflammatory properties. Research indicates that its extracts can prevent inflammatory responses in human macrophages stimulated by charcoal pyrolysis smoke. Furthermore, the plant is effective in treating inflammatory responses caused by the highly oxidative pyrolysis smoke released from the re-utilization of agro-industrial leftovers. Studies have also demonstrated its potential to treat lung cancer by inhibiting the migration and invasion of non-small cell lung cancer cells. These diverse biological activities highlight the plant's significant therapeutic value across multiple health conditions.
Preparations
Artemisia lactiflora is prepared as an extract through the processing of its leaves. This plant is also prepared as various fractions using solvents of different polarities. Specifically, the butanol fraction is prepared from the plant to achieve high phenolic and flavonoid scavenging activity. Additionally, the ethyl acetate fraction is prepared to demonstrate significant anti-inflammatory effects. These different preparations, including the general plant fractions, are used to study the medicinal properties of the species.
Parts used
Artemisia lactiflora is a Chinese-origin plant recognized for its unique phytochemicals and potential medicinal properties. In recent scientific investigations, researchers specifically utilized the leaf of this plant to extract various bioactive compounds. These leaf extracts were fractionated with different solvents to evaluate their total phenolics, flavonoids, and antioxidant capacities. The study focused on how these leaf-derived fractions could mitigate inflammatory responses in human macrophages stimulated by smoke. Ultimately, the findings suggest that the plant's leaves possess significant anti-inflammatory potential by inhibiting key pro-inflammatory pathways.